Borden Lacy
-
Vanderbilt University School of Medicine Basic Sciences adds Carterra’s LSAXT instrument to speed drug and vaccine research and advance patient care
Carterra Inc. and the Vanderbilt University School of Medicine Basic Sciences announced the addition of the Carterra LSAXT label-free interaction analysis platform to the Center for Structural Biology. Vanderbilt and Vanderbilt University Medical Center researchers will be able to discover and characterize large molecules including antibodies. Read MoreSep 26, 2024
-
Vanderbilt University launches sustainable lab program
Vanderbilt Environmental Health, Safety and Sustainability is launching the Vanderbilt Sustainable Labs program, which provides guidance for laboratory members to reduce the environmental impact of their lab activities. Read MoreApr 17, 2024
-
Nominations open for ninth cohort of Chancellor Faculty Fellows
Nominations are open for the ninth cohort of the Chancellor Faculty Fellows, a program that awards select faculty with financial and institutional support at a key moment in their careers. Learn more and read about past awardees' successes. Read MoreFeb 6, 2023
-
Vanderbilt postdoctoral fellows recognized at 2021 Spring Postdoc Awards
The Vanderbilt Postdoctoral Association and Office of Postdoctoral Affairs announced its 2021 award winners May 24. Postdoctoral fellows, commonly known as postdocs, are professionals who have earned doctoral degrees and are, in most cases, temporarily pursuing additional scholarly training, experience and research progress necessary for a wide range of career paths. Read MoreMay 25, 2021
-
Borden Lacy named director of Vanderbilt’s Center for Structural Biology
Borden Lacy, Edward and Nancy Fody Chair in Pathology and professor of biochemistry and pathology, microbiology and immunology, has been named director of the Vanderbilt Center for Structural Biology, effective Jan. 1. Read MoreJan 11, 2021
-
Structural views of a C. diff toxin
D. Borden Lacy and colleagues used cryo-electron microscopy to define the structure of a C. diff toxin, providing a framework for the design of novel therapeutics. Read MoreJan 10, 2020
-
Versatile C. difficile blocker
New research reveals a unique mechanism of C. difficile toxin neutralization by a monoclonal antibody, suggesting new therapeutic approaches. Read MoreJan 26, 2018
-
15 faculty members elected as AAAS fellows
Fifteen Vanderbilt faculty members conducting a range of biomedical and clinical research have been elected fellows of the American Association for the Advancement of Science. Six of the 15 have received funding through the university’s Trans-Institutional Programs initiative, which facilitates research and teaching collaborations across disciplines and are a core pillar of the university’s Academic Strategic Plan. Read MoreNov 20, 2017
-
Inaugural Stanley Cohen Lecture is March 4
Ray Stevens, the Provost Professor of Chemistry and Molecular Biology at the University of Southern California, presents the inaugural Stanley Cohen Lecture Friday, March 4. Read MoreFeb 23, 2016
-
Crystal structure reveals secrets of virulent bacterium
Researchers at Vanderbilt University Medical Center have obtained the crystal structure of a toxin from the bacterium Clostridium difficile (“C. diff”) — the leading cause of hospital-acquired diarrhea in the United States. Read MoreJan 14, 2016
-
Study identifies C. diff toxin receptor, suggests new treatment approaches
Vanderbilt University investigators have identified a cellular receptor for a toxin from Clostridium difficile (“C. diff”) — the leading cause of hospital-acquired diarrhea in the United States. Read MoreJun 4, 2015
-
VUMC Academic Enterprise Faculty Award winners announced
The 2015 Vanderbilt University Medical Center Academic Enterprise Faculty Awards, which were presented during the May 19 Spring Faculty meeting, included awards for Excellence in Teaching and Outstanding Contributions to Research. Read MoreMay 26, 2015
-
Chancellor Faculty Fellows Program to Advance Trans-institutional Scholarship
Fifteen faculty members from diverse disciplines have been selected as the first cohort of the Chancellor Faculty Fellows program. Read MoreMar 23, 2015
-
Cutting-edge research to be showcased in May
(Vanderbilt University) Potentially “game-changing” research at Vanderbilt University on infectious diseases, population health and health policy will be showcased during two interactive presentations May 15 and May 22. A segment of the Flexner Discovery Lecture Series, the new “Vanderbilt Cutting-edge Discovery” discussions are highlights of recent presentations… Read MoreMay 1, 2014
-
Vanderbilt awarded $16.5 million agreement to determine how toxic agents affect human cells
Vanderbilt University has been awarded a Cooperative Agreement with the Defense Advanced Research Projects Agency and the Army Research Office that is worth up to $16.5 million over five years. Read MoreMar 3, 2014
-
Defusing ‘C. diff’ infection
Clostridium difficile on the intestinal lining. (Wellcome Images) Clostridium difficile (“C. diff”) infection is a leading cause of hospital-associated diarrhea, and the frequency and severity of infections are on the rise. D. Borden Lacy, Ph.D., associate professor of Pathology, Microbiology and Immunology, and colleagues recently demonstrated that the C. Read MoreNov 8, 2013
-
Lacy’s crystallographic research achievements recognized
D. Borden Lacy, Ph.D., associate professor of Pathology, Microbiology and Immunology, and Biochemistry, will receive the 2014 Margaret Etter Award from the American Crystallographic Association (ACA) for outstanding achievement and exceptional potential in crystallographic research demonstrated by a scientist at an early stage of their independent career. Read MoreSep 19, 2013